Markus Gumpinger
Overview
Explore the profile of Markus Gumpinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Birner K, Reiter G, Steiner I, Zarghami A, Sadeghipour A, Schurer-Waldheim S, et al.
Invest Ophthalmol Vis Sci
. 2025 Mar;
66(3):26.
PMID: 40067294
Purpose: The purpose of this study was to define structure-function correlation of geographic atrophy (GA) on optical coherence tomography (OCT) and functional testing on microperimetry (MP) based on deep-learning (DL)-quantified...
2.
Birner K, Coulibaly L, Schrittwieser J, Steiner I, Mohamed H, Schurer-Waldheim S, et al.
Acta Ophthalmol
. 2024 Dec;
PMID: 39731225
Purpose: The relationship between retinal morphology, as assessed by optical coherence tomography (OCT), and retinal function in microperimetry (MP) has not been well studied, despite its increasing importance as an...
3.
Birner K, Reiter G, Steiner I, Deak G, Mohamed H, Schurer-Waldheim S, et al.
Sci Rep
. 2024 Nov;
14(1):28165.
PMID: 39548108
To examine the morphological impact of deep learning (DL)-quantified biomarkers on point-wise sensitivity (PWS) using microperimetry (MP) and optical coherence tomography (OCT) in intermediate AMD (iAMD). Patients with iAMD were...
4.
Coulibaly L, Birner K, Zarghami A, Gumpinger M, Schurer-Waldheim S, Fuchs P, et al.
Am J Ophthalmol
. 2024 Nov;
271:347-359.
PMID: 39547308
Purpose: Growing interest in microperimetry (MP) or fundus-controlled perimetry as a targeted psychometric testing method in geographic atrophy (GA) is warranted because of the disease subclinical/extrafoveal appearance or preexisting foveal...
5.
Mares V, Reiter G, Gumpinger M, Leigang O, Bogunovic H, Barthelmes D, et al.
Acta Ophthalmol
. 2024 Nov;
PMID: 39540601
Purpose: To quantify ellipsoid zone (EZ) loss during anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) and correlate these findings with nAMD disease activity using artificial intelligence-based algorithms. Methods: Spectral...
6.
Stino H, Birner K, Hinterhuber L, Struppe A, Gumpinger M, Schurer-Waldheim S, et al.
Sci Rep
. 2024 Oct;
14(1):23342.
PMID: 39375434
To evaluate the intra- and interdevice repeatability of microperimetry (MP) assessments in patients with diabetic macular edema (DME) two consecutive MP testings (45 fovea-centered stimuli, 4-2 staircase strategy) were performed...
7.
Prenner V, Reiter G, Fuchs P, Birner K, Frank S, Coulibaly L, et al.
Can J Ophthalmol
. 2024 Jun;
60(1):42-49.
PMID: 38901467
Objective: To compare the visibility and accessibility of the outer retina in neovascular age-related macular degeneration (nAMD) between 2 OCT devices. Methods: In this prospective, cross-sectional exploratory study, differences in...
8.
Kostolna K, Reiter G, Frank S, Coulibaly L, Fuchs P, Roggla V, et al.
Ophthalmol Sci
. 2024 Feb;
4(3):100456.
PMID: 38317867
Objective: Treatment decisions in neovascular age-related macular degeneration (nAMD) are mainly based on subjective evaluation of OCT. The purpose of this cross-sectional study was to provide a comparison of qualitative...